-
Something wrong with this record ?
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
P. Musto, J. Salmanton-García, N. Sgherza, R. Bergantim, F. Farina, A. Glenthøj, G. Cengiz Seval, B. Weinbergerová, V. Bonuomo, YM. Bilgin, J. van Doesum, O. Jaksic, B. Víšek, I. Falces-Romero, M. Marchetti, J. Dávila-Valls, S. Martín-Pérez, M....
Language English Country England, Great Britain
Document type Journal Article
PubMed
38050405
DOI
10.1002/hon.3240
Knihovny.cz E-resources
- MeSH
- COVID-19 * MeSH
- Humans MeSH
- Multiple Myeloma * therapy MeSH
- Pandemics MeSH
- Registries MeSH
- SARS-CoV-2 MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Patients affected by multiple myeloma (MM) have an increased risk of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection and subsequent coronavirus (20)19 disease (COVID-19)-related death. The changing epidemiological and therapeutic scenarios suggest that there has been an improvement in severity and survival of COVID-19 during the different waves of the pandemic in the general population, but this has not been investigated yet in MM patients. Here we analyzed a large cohort of 1221 patients with MM and confirmed SARS-CoV-2 infection observed between February 2020, and August 2022, in the EPICOVIDEHA registry from 132 centers around the world. Median follow-up was 52 days for the entire cohort and 83 days for survivors. Three-hundred and three patients died (24%) and COVID-19 was the primary reason for death of around 89% of them. Overall survival (OS) was significantly higher in vaccinated patients with both stable and active MM versus unvaccinated, while only a trend favoring vaccinated patients was observed in subjects with responsive MM. Vaccinated patients with at least 2 doses showed a better OS than those with one or no vaccine dose. Overall, according to pandemic waves, mortality rate decreased over time from 34% to 10%. In multivariable analysis, age, renal failure, active disease, hospital, and intensive care unit admission, were independently associated with a higher number of deaths, while a neutrophil count above 0.5 × 109 /L was found to be protective. This data suggests that MM patients remain at risk of SARS-CoV-2 infection even in the vaccination era, but their clinical outcome, in terms of OS, has progressively improved throughout the different viral phases of the pandemic.
Ankara University Ankara Turkey
ASST Grande Ospedale Metropolitano Niguarda Milan Italy
Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo Alessandria Italy
Azienda Ospedaliera San Gerardo Monza Monza Italy
Centro Hospitalar e Universitário São João Porto Portugal
CIBERINFEC Instituto de Salud Carlos 3 Madrid Spain
Clinica Malattie Infettive Ospedale Policlinico San Martino IRCCS Genoa Italy
Complejo Hospitalario de Navarra Iruña Pamplona Spain
Departament de Medicina Universitat Autònoma de Barcelona Bellaterra Spain
Department of Clinical and Biological Sciences University of Turin Turin Italy
Department of Health Sciences University of Genoa Genoa Italy
Department of Hematology and Oncology Medical University of Innsbruck Innsbruck Austria
Department of Hematology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
Department of Hematology Research Unit Hospital Universitario de Burgos Burgos Spain
Department of Hematology University Hospital Dubrava Zagreb Croatia
Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden
Department of Internal Medicine ADRZ Goes Netherlands
Department of Medicine Section of Hematology University of Verona Verona Italy
Department of Nephrology and Infectious diseases AZ Sint Jan Brugge Oostende AV Brugge Belgium
Division of Hematology Dokuz Eylul University Izmir Turkey
Ematologia con Trapianto Ospedale Dimiccoli Barletta Barletta Italy
Federal University of Rio de Janeiro Rio de Janeiro Brazil
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
Fundacion Jimenez Diaz University Hospital Health Research Institute IIS FJD Madrid Spain
German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany
Hematology and Stem Cell transplan Unit Vito Fazzi Italy
Hematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome Italy
Hematology and Stem Cell Transplantation Unit AOUC Policlinico Bari Italy
Hematology Department Hospital Universitario de Salamanca Salamanca Spain
Hematology Department of Biomedicine and Prevention University of Rome Tor Vergata Rome Italy
Hematology Unit ASST Spedali Civili Brescia Italy
Hematology Unit Center for Translational Medicine Azienda USL Toscana NordOvest Livorno Italy
Hematology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
Hospital Clinic Barcelona Spain
Hospital Escuela de Agudos Dr Ramón Madariaga Posadas Argentina
Hospital Nuestra Señora de Sonsoles Ávila Spain
Hospital Universitario Puerta de Hierro Majadahonda Spain
Hospital University of Parma Hematology and Bone Marrow Unit Parma Italy
IBSAL Centro de Investigación del Cáncer IBMCC Salamanca Spain
Institute of Hematology and Blood Transfusion Prague Czech Republic
IRCCS Ospedale San Raffaele Milan Italy
Istituto Oncologico della Svizzera Italiana Bellinzona Switzerland
King's College Hospital London UK
King's College London London UK
La Paz University Hospital Madrid Spain
NIHR Oxford Biomedical Research Centre Churchill Hospital Oxford UK
Oncology Center Mansoura University Mansoura Egypt
Portuguese Institute of Oncology Lisbon Portugal
San Luigi Gonzaga Hospital Orbassano Orbassano Italy
School of Medicine University of Zagreb Zagreb Croatia
Università Milano Bicocca Milan Italy
University Clinical Center Serbia Medical Faculty University Belgrade Belgrade Serbia
University Hospital Centre Rijeka Rijeka Croatia
University Hospital Centre Zagreb Zagreb Croatia
University Hospital Hradec Králové Hradec Králové Czech Republic
University Hospital Olomouc Olomouc Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007758
- 003
- CZ-PrNML
- 005
- 20240423160234.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/hon.3240 $2 doi
- 035 __
- $a (PubMed)38050405
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Musto, Pellegrino $u Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy $u Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy
- 245 10
- $a Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry / $c P. Musto, J. Salmanton-García, N. Sgherza, R. Bergantim, F. Farina, A. Glenthøj, G. Cengiz Seval, B. Weinbergerová, V. Bonuomo, YM. Bilgin, J. van Doesum, O. Jaksic, B. Víšek, I. Falces-Romero, M. Marchetti, J. Dávila-Valls, S. Martín-Pérez, M. Nucci, A. López-García, F. Itri, C. Buquicchio, L. Verga, K. Piukovics, M. Navrátil, GP. Collins, M. Jiménez, NS. Fracchiolla, J. Labrador, L. Prezioso, E. Rossi, N. Čolović, S. Meers, A. Kulasekararaj, A. Cuccaro, O. Blennow, T. Valković, U. Sili, MP. Ledoux, J. Batinić, F. Passamonti, M. Machado, RF. Duarte, CB. Poulsen, GA. Méndez, I. Espigado, F. Demirkan, M. Čerňan, C. Cattaneo, V. Petzer, G. Magliano, C. Garcia-Vidal, S. El-Ashwah, M. Gomes-Da-Silva, A. Vena, I. Ormazabal-Vélez, J. van Praet, M. Dargenio, C. De-Ramón, MI. Del Principe, J. Marques-De-Almeida, D. Wolf, T. Szotkowski, A. Obr, GM. Çolak, A. Nordlander, M. Izuzquiza, A. Cabirta, GPM. Zambrotta, R. Cordoba, P. Žák, E. Ammatuna, J. Mayer, O. Ilhan, R. García-Sanz, M. Quattrone, E. Arellano, R. Nunes-Rodrigues, Z. Emarah, TF. Aiello, M. Hanakova, Z. Ráčil, M. Bavastro, A. Limongelli, L. Rahimli, F. Marchesi, OA. Cornely, L. Pagano
- 520 9_
- $a Patients affected by multiple myeloma (MM) have an increased risk of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection and subsequent coronavirus (20)19 disease (COVID-19)-related death. The changing epidemiological and therapeutic scenarios suggest that there has been an improvement in severity and survival of COVID-19 during the different waves of the pandemic in the general population, but this has not been investigated yet in MM patients. Here we analyzed a large cohort of 1221 patients with MM and confirmed SARS-CoV-2 infection observed between February 2020, and August 2022, in the EPICOVIDEHA registry from 132 centers around the world. Median follow-up was 52 days for the entire cohort and 83 days for survivors. Three-hundred and three patients died (24%) and COVID-19 was the primary reason for death of around 89% of them. Overall survival (OS) was significantly higher in vaccinated patients with both stable and active MM versus unvaccinated, while only a trend favoring vaccinated patients was observed in subjects with responsive MM. Vaccinated patients with at least 2 doses showed a better OS than those with one or no vaccine dose. Overall, according to pandemic waves, mortality rate decreased over time from 34% to 10%. In multivariable analysis, age, renal failure, active disease, hospital, and intensive care unit admission, were independently associated with a higher number of deaths, while a neutrophil count above 0.5 × 109 /L was found to be protective. This data suggests that MM patients remain at risk of SARS-CoV-2 infection even in the vaccination era, but their clinical outcome, in terms of OS, has progressively improved throughout the different viral phases of the pandemic.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $7 D000086382
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a pandemie $7 D058873
- 650 12
- $a mnohočetný myelom $x terapie $7 D009101
- 650 _2
- $a registrace $7 D012042
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Salmanton-García, Jon $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany $u Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany $1 https://orcid.org/0000000267668297
- 700 1_
- $a Sgherza, Nicola $u Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy
- 700 1_
- $a Bergantim, Rui $u Centro Hospitalar e Universitário São João, Porto, Portugal $1 https://orcid.org/0000000278119509
- 700 1_
- $a Farina, Francesca $u IRCCS Ospedale San Raffaele, Milan, Italy
- 700 1_
- $a Glenthøj, Andreas $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Cengiz Seval, Guldane $u Ankara University, Ankara, Turkey
- 700 1_
- $a Weinbergerová, Barbora $u Department of Internal Medicine - Hematology and Oncology, Masaryk University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000164602471
- 700 1_
- $a Bonuomo, Valentina $u Department of Medicine, Section of Hematology, University of Verona, Verona, Italy $u Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
- 700 1_
- $a Bilgin, Yavuz M $u Department of Internal Medicine, ADRZ, Goes, Netherlands
- 700 1_
- $a van Doesum, Jaap $u University Medical Center Groningen, Groningen, Netherlands
- 700 1_
- $a Jaksic, Ozren $u Department of Hematology, University Hospital Dubrava, Zagreb, Croatia
- 700 1_
- $a Víšek, Benjamín $u University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Falces-Romero, Iker $u La Paz University Hospital, Madrid, Spain $u CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a Marchetti, Monia $u Azienda Ospedaliera Nazionale SS, Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
- 700 1_
- $a Dávila-Valls, Julio $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain
- 700 1_
- $a Martín-Pérez, Sonia $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain
- 700 1_
- $a Nucci, Marcio $u Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- 700 1_
- $a López-García, Alberto $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
- 700 1_
- $a Itri, Federico $u San Luigi Gonzaga Hospital - Orbassano, Orbassano, Italy
- 700 1_
- $a Buquicchio, Caterina $u Ematologia con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy
- 700 1_
- $a Verga, Luisa $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy
- 700 1_
- $a Piukovics, Klára $u Department of Internal Medicine, South Division Faculty of Medicine University of Szeged, Szeged, Hungary
- 700 1_
- $a Navrátil, Milan $u Head of the ICU and Transplant Unit, Department of Hematooncology, University Hospital of Ostrava, Ostrava-Poruba, Czech Republic
- 700 1_
- $a Collins, Graham P $u NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK
- 700 1_
- $a Jiménez, Moraima $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain $u Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- 700 1_
- $a Fracchiolla, Nicola S $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy $1 https://orcid.org/0000000253568690
- 700 1_
- $a Labrador, Jorge $u Department of Hematology, Research Unit, Hospital Universitario de Burgos, Burgos, Spain $1 https://orcid.org/0000000236960287
- 700 1_
- $a Prezioso, Lucia $u Hospital University of Parma - Hematology and Bone Marrow Unit, Parma, Italy
- 700 1_
- $a Rossi, Elena $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy
- 700 1_
- $a Čolović, Natasha $u University Clinical Center Serbia, Medical Faculty University Belgrade, Belgrade, Serbia $1 https://orcid.org/0000000213214812
- 700 1_
- $a Meers, Stef $u AZ KLINA, Brasschaat, Belgium
- 700 1_
- $a Kulasekararaj, Austin $u King's College Hospital, London, UK $u King's College London, London, UK
- 700 1_
- $a Cuccaro, Annarosa $u Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy
- 700 1_
- $a Blennow, Ola $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Valković, Toni $u University Hospital Centre Rijeka, Rijeka, Croatia $u Croatian Cooperative Group for Hematological Diseases (CROHEM), Faculty of Medicine and Faculty of Health Studies University of Rijeka, Rijeka, Croatia
- 700 1_
- $a Sili, Uluhan $u Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, Istanbul, Turkey
- 700 1_
- $a Ledoux, Marie-Pierre $u ICANS, Strasbourg, France
- 700 1_
- $a Batinić, Josip $u University Hospital Centre Zagreb, Zagreb, Croatia $u School of Medicine University of Zagreb, Zagreb, Croatia
- 700 1_
- $a Passamonti, Francesco $u Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy
- 700 1_
- $a Machado, Marina $u Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
- 700 1_
- $a Duarte, Rafael F $u Hospital Universitario Puerta de Hierro, Majadahonda, Spain
- 700 1_
- $a Poulsen, Christian Bjørn $u Zealand University Hospital, Roskilde, Denmark
- 700 1_
- $a Méndez, Gustavo-Adolfo $u Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina
- 700 1_
- $a Espigado, Ildefonso $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain
- 700 1_
- $a Demirkan, Fatih $u Division of Hematology, Dokuz Eylul University, Izmir, Turkey
- 700 1_
- $a Čerňan, Martin $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Cattaneo, Chiara $u Hematology Unit, ASST-Spedali Civili, Brescia, Italy $1 https://orcid.org/0000000300313237
- 700 1_
- $a Petzer, Verena $u Department of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
- 700 1_
- $a Magliano, Gabriele $u ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- 700 1_
- $a Garcia-Vidal, Carolina $u Hospital Clinic, Barcelona, Spain
- 700 1_
- $a El-Ashwah, Shaimaa $u Oncology Center, Mansoura University, Mansoura, Egypt
- 700 1_
- $a Gomes-Da-Silva, Maria $u Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a Vena, Antonio $u Clinica Malattie Infettive. Ospedale Policlinico San Martino - IRCCS, Genoa, Italy $u Department of Health Sciences, University of Genoa, Genoa, Italy
- 700 1_
- $a Ormazabal-Vélez, Irati $u Complejo Hospitalario de Navarra, Iruña-Pamplona, Spain
- 700 1_
- $a van Praet, Jens $u Department of Nephrology and Infectious diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium $1 https://orcid.org/0000000271257001
- 700 1_
- $a Dargenio, Michelina $u Hematology and Stem Cell transplan Unit, Vito Fazzi, Italy
- 700 1_
- $a De-Ramón, Cristina $u Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain $u IBSAL, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain
- 700 1_
- $a Del Principe, Maria Ilaria $u Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
- 700 1_
- $a Marques-De-Almeida, Joyce $u Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
- 700 1_
- $a Wolf, Dominik $u Department of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
- 700 1_
- $a Szotkowski, Tomáš $u University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Obr, Aleš $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Çolak, Gökçe Melis $u Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, Istanbul, Turkey
- 700 1_
- $a Nordlander, Anna $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Izuzquiza, Macarena $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain $u Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- 700 1_
- $a Cabirta, Alba $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- 700 1_
- $a Zambrotta, Giovanni Paolo Maria $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy
- 700 1_
- $a Cordoba, Raul $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
- 700 1_
- $a Žák, Pavel $u University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Ammatuna, Emanuele $u University Medical Center Groningen, Groningen, Netherlands
- 700 1_
- $a Mayer, Jiří $u Department of Internal Medicine - Hematology and Oncology, Masaryk University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Ilhan, Osman $u Ankara University, Ankara, Turkey
- 700 1_
- $a García-Sanz, Ramón $u IBSAL, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain $u Head of Molecular Biology an HLA Unit, Department of Hematology, University Hospital of Salamanca (HUS/IBSAL/CIBERONC), Salamanca, Spain
- 700 1_
- $a Quattrone, Martina $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy
- 700 1_
- $a Arellano, Elena $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain
- 700 1_
- $a Nunes-Rodrigues, Raquel $u Portuguese Institute of Oncology, Lisbon, Portugal $1 https://orcid.org/0000000283474281
- 700 1_
- $a Emarah, Ziad $u Oncology Center, Mansoura University, Mansoura, Egypt $1 https://orcid.org/0000000306222598
- 700 1_
- $a Aiello, Tommaso Francesco $u Hospital Clinic, Barcelona, Spain
- 700 1_
- $a Hanakova, Michaela $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Ráčil, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Bavastro, Martina $u Clinica Malattie Infettive. Ospedale Policlinico San Martino - IRCCS, Genoa, Italy $u Department of Health Sciences, University of Genoa, Genoa, Italy
- 700 1_
- $a Limongelli, Alessandro $u Clinica Malattie Infettive. Ospedale Policlinico San Martino - IRCCS, Genoa, Italy $u Department of Health Sciences, University of Genoa, Genoa, Italy
- 700 1_
- $a Rahimli, Laman $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany $u Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Marchesi, Francesco $u Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- 700 1_
- $a Cornely, Oliver A $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany $u Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany
- 700 1_
- $a Pagano, Livio $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy
- 773 0_
- $w MED00002019 $t Hematological oncology $x 1099-1069 $g Roč. 42, č. 1 (2024), s. e3240
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38050405 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160230 $b ABA008
- 999 __
- $a ok $b bmc $g 2081629 $s 1217525
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 42 $c 1 $d e3240 $e 20231204 $i 1099-1069 $m Hematological oncology $n Hematol Oncol $x MED00002019
- LZP __
- $a Pubmed-20240412
